The gonadotropin-releasing hormone antagonist abarelix depot versus luteinizing hormone releasing hormone agonists leuprolide or goserelin: initial results of endocrinological and biochemical efficacies in patients with prostate cancer. [electronic resource]
Producer: 20010524Description: 1585-9 p. digitalISSN:- 0022-5347
- Aged
- Aged, 80 and over
- Androgen Antagonists -- therapeutic use
- Antineoplastic Agents, Hormonal -- therapeutic use
- Delayed-Action Preparations
- Dihydrotestosterone -- blood
- Follicle Stimulating Hormone -- blood
- Gonadotropin-Releasing Hormone -- agonists
- Goserelin -- therapeutic use
- Humans
- Injections, Intramuscular
- Leuprolide -- therapeutic use
- Luteinizing Hormone -- blood
- Male
- Middle Aged
- Oligopeptides -- administration & dosage
- Prospective Studies
- Prostate-Specific Antigen -- blood
- Prostatic Neoplasms -- blood
- Testis -- drug effects
- Testosterone -- blood
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.